• The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.

  • 2025/02/27
  • 再生時間: 14 分
  • ポッドキャスト

The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.

  • サマリー

  • In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a conversation about innovation in testing for sexually transmitted infections (STI). Topics include:

    • The advantages and challenges of new types of specimen collection and testing methods, including over-the-counter, at-home, and point-of-care options.
    • Implications home testing has for clinicians and public health.
    • Barriers to making more at-home collection and over-the-counter testing products for STI testing.
    • The growing need for tests to detect resistance markers as antimicrobial resistance increases.
    続きを読む 一部表示

あらすじ・解説

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a conversation about innovation in testing for sexually transmitted infections (STI). Topics include:

  • The advantages and challenges of new types of specimen collection and testing methods, including over-the-counter, at-home, and point-of-care options.
  • Implications home testing has for clinicians and public health.
  • Barriers to making more at-home collection and over-the-counter testing products for STI testing.
  • The growing need for tests to detect resistance markers as antimicrobial resistance increases.

The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。